Microkeratome creates high-quality, predictable flaps and smoothbeds, studies show
May 15th 2006Studies evaluating the new Zyoptix XP microkeratome (Bausch &Lomb) indicate that it performs safely and reliably to cut LASIKflaps of a reproducible thickness with a standard deviation thatmatches or exceeds results reported for the femtosecond laser(IntraLase).
Mechanical microkeratomes maintain place in surgery
May 15th 2006Barranquilla, Colombia-Mechanical microkeratomes have anumber of advantages compared with the femtosecond laser"macrokeratome" and should continue to be regarded as safe andefficient instruments for LASIK flap creation, according to CesarA. Carriazo, MD.
Changes in pegaptanib labeling prompted by adverse reactions
May 15th 2006New York-On March 6, OSI Pharmaceuticals/EyetechPharmaceuticals and Pfizer issued changes in the product labelingfor pegaptanib sodium injection (Macugen), which was approved bythe FDA for the treatment of neovascular age-related maculardegeneration in December 2004.
Ophthalmic committee develops guidelines for treating patients atrisk for ectasia
May 15th 2006San Francisco-A team of ophthalmologists founded the EctasiaCommittee in the hopes of summarizing the current knowledgeregarding ectasia and refractive surgery and developingrecommendations to prevent the development of the condition,explained Eric D. Donnenfeld, MD, at the annual meeting of theAmerican Society of Cataract and Refractive Surgery (ASCRS).
Cause of recent TASS outbreak unknown
May 15th 2006Teams of investigators are searching for the source of a recentoutbreak of toxic anterior segment syndrome (TASS) followingcataract surgery that has been reported in sites throughout NorthAmerica since March. The current increased incidence in theoccurrence of TASS appears to be unrelated to an outbreak thatoccurred last fall, which was linked to endotoxin contamination inthe balanced salt solution (BSS) product (Endosol, CytosolOphthalmics/Advanced Medical Optics).
Treat as bacterial infection until fungus is positive, experts say
May 15th 2006Pittsburgh-U.S. health officials are recommending thatophthalmic professionals who see patients with microbial keratitisshould consider whether it might be caused by the Fusarium fungus,rather than assume it is a bacterial infection as they might havein the past.
Health officials scramble to find source of fungal keratitis cases
May 15th 2006Atlanta-With a growing list of states reporting suspectedcases of an uncommon fungal keratitis, the Centers for DiseaseControl and Prevention (CDC) and other U.S. health authoritiescontinue to search for the cause of an apparent outbreak of therare fungal infection among soft contact-lens wearers.
Cogan Lecture: Iron-induced oxidative damage as a potential factorin AMD
May 2nd 2006Iron overload may join several other factors as a contributor toage-related macular degeneration (AMD), suggests research beingcarried out in the lab of Joshua L. Dunaief, MD, PhD, assistantprofessor of ophthalmology, F.M. Kirby Center for MolecularOphthalmology at the Scheie Eye Institute, University ofPennsylvania, Philadelphia.
Cogan Lecture: Iron-induced oxidative damage as a potential factorin AMD
May 2nd 2006Iron overload may join several other factors as a contributor toage-related macular degeneration (AMD), suggests research beingcarried out in the lab of Joshua L. Dunaief, MD, PhD, assistantprofessor of ophthalmology, F.M. Kirby Center for MolecularOphthalmology at the Scheie Eye Institute, University ofPennsylvania, Philadelphia.
Friedenwald Lecture: The limits of human vision
May 2nd 2006David R. Williams, PhD, of the University of Rochester, Rochester, NY, received the Friedenwald Award for his studies of human optics, human cone receptors, and color vision, and for his work on the application of adaptive optics, a method to compensate for optical effects affecting ideal visualization of a target, to human retinal imaging.
SD-OCT provides better structural evaluation of eyes
May 2nd 2006Ultra high-speed, high-resolution spectral domain optical coherencetomography (SD-OCT) seems to have surpassed the low-resolutionslow-speed OCT and provides video images of structures in eyes withglaucoma that demonstrate the minute details of the glaucomatoustissues.
Topical glaucoma therapy falls short of goals, physician says
May 2nd 2006With glaucoma being the second leading cause of blindness in theworld, treatment consisting of eye drops has inherent problems andstops only about half of the damage. While the effect of treatmentwithin the confines of a clinical trial far exceeds those ofpatients being treated outside the framework of a clinical trial,the reality is that most patients are in the "real world,"according to Harry Quigley, MD, who spoke at the annual meeting ofthe Association for Research in Vision and Ophthalmology.
Rosiglitazone may delay progression of severe diabetic retinopathy
May 2nd 2006Rosiglitazone, an oral medication for diabetes with antiangiogenicproperties, may delay ocular neovascularization in patients withsevere diabetic retinopathy at baseline, according to results of alongitudinal chart review study, said Lucy Q. Shen, MD, HarvardMedical School, Boston.
Women unaware of dry eye's link to menopause, survey finds
May 1st 2006A March survey showed that 62% of menopausal and perimenopausal women reported dry eye symptoms, yet 16% of women experiencing dry eye symptoms realized dry eye was a symptom of menopause. Of the women experiencing dry eye symptoms, less than 59% spoke to a doctor about it and about 58% used over-the-counter eye drops to treat the symptoms.
Liquid gel therapy broadens role of dry eye product line
May 1st 2006Miami-The introduction of Systane Free Lubricant Eye Drops (Alcon Laboratories Inc.) has further diversified the company's product line to enable optimization of artificial tear treatment for the broad spectrum of patients suffering with dry eye, said Terrence P. O'Brien, MD.
Dry eye surface disease: inflammation or osmolarity?
May 1st 2006Woburn, MA-The chicken-and-egg controversy has swirled for years about what causes what in dry eye syndrome, but the scales are tipping in favor of elevated tear film osmolarity as the cause of dry eye surface disease, based on the latest research.
Dry eye is here to stay but all treatments not equal
May 1st 2006New York-It's more an evolution than a revolution, but ophthalmologists' stance on dry eye is unquestionably changing. Definitions and treatments are being revised, and this process will continue as ongoing research yields new findings.
Managing dry eye disease now and in the future
May 1st 2006Our understanding of dry eye has evolved and improved dramatically, as well as our ability to diagnose and treat this multi-faceted disorder. Despite its prevalence, estimated at 11% to 22% of the general population,1 dry eye is not always easy to diagnose differentially from other ocular surface disorders. Without accurate diagnosis, patients may not receive the proper treatment and education they need.